28 June 2023 in Autoimmunity
Nowadays, data concerning the risk of autoimmune disease after SARS-CoV-2 (COVID-19) vaccination is controversial. The aim of this single centre prospective follow-up study was to evaluate whether healthcare workers (HCWs) vaccinated with BNT162b2 mRNA and mRNA-1273 will show a development and/or a persistence of autoantibodies, focussing on the detection of antibodies against nuclear antigens (antinuclear antibodies, ANA). We enrolled 155 HCWs, however only 108 of them received the third dose and were considered for further analysis. Blood samples were collected before vaccine inoculation (T0), at 3 (T1) and 12 months (T2) after the first dose. All samples were analysed for the presence of a) ANA using indirect Immunofluorescence [IIF] (dilutions of 1:80, 1:160. 1:320 and 1:640), and anti-smooth muscle antibodies (ASMA); b) anti-myeloperoxidase (anti-MPO), anti-proteinase 3 (anti-PR3) and anti-citrullinated peptide antibodies (aCCP) [FEIA]; c) anti-phospholipid antibodies (anticardiolipin [aCL], anti-beta-2- glycoprotein I [anti-ß-2GPI] (Chemiluminescence). Line-blot technology was performed using the following kit: EUROLINE ANA profile 3 plus DFS70 (IgG). Our research suggests that mRNA based anti-SARSCoV-2 vaccines can induce the production of de novo ANA in 22/77(28,57%) of subjects and that the percentage of positivity seems to be directly correlated to the number of vaccine expositions: 6/77 (7,79%) after 2 doses; 16/77 (20,78%) after 3 doses. Since it is known that hyperstimulation of the immune system could lead to autoimmunity, these preliminary results seem to further sustain the idea that the hyperstimulation of the immune system might lead to an autoinflammatory mechanism and eventually to autoimmune disorders. However, the link between SARS-CoV-2 vaccination and the development of autoimmune diseases needs to be further investigated.
2 March 2023 in Working Paper of Public Health
Obiettivi: Lo scopo del presente lavoro è stato quello di esplorare l’impatto psicologico a lungo termine della pandemia da COVID-19 negli operatori sanitari e in altri professionisti che lavorano presso l’Azienza Ospedaliera “SS Antonio e Biagio, e Cesare Arrigo” di Alessandria. Materiali e Metodi: È stato condotto uno studio osservazionale prospettico monocentrico su 112 operatori dell’Azienda Ospedaliera attraverso la somministrazione di un questionario on-line. I dati sono stati raccolti a tra l’1 e il 30 aprile 2021. Il questionario comprendeva un’autovalutazione delle informazioni socio-demografiche, cliniche, lavorative e relative al COVID-19 e la percezione del rischio. Inoltre, includeva la versione on-line di questionari psicologici validati in lingua italiana: Scala dell’impatto dell’Evento-Rivista (IES-R), Scala di Depressione, Ansia e Stress (DASS-21), Insomnia Severity Index (ISI), Coping Orientation to the Problems Experienced - Nuova Versione Italiana (COPE-NVI- 25), e Scala della Qualità di Vita Professionale (ProQOL-5). Risultati: L’analisi dei dati mostra che i lavoratori dell’Azienda Ospedaliera partecipanti allo studio, presentano percentuali moderate di sintomatologia da stress post-traumatico (40,2%), depressiva (40.2%), ansiosa (28.6%), da stress (44.6%) e insonnia (16.1%). La categoria dei lavoratori in ambito amministrativo mostra maggiori sintomi ansiosi e di stress post-traumatico. Le strategie di coping maggiormente utilizzate nel nostro campione sono l’attitudine positiva, l’orientamento al problema e il sostegno sociale. Il sottogruppo di lavoratori a diretto contatto con i pazienti mostra livelli moderati di compassion-satisfaction e bassi livelli di stress traumatico secondario e burn-out. Conclusioni: Dai risultati del presente lavoro si è osservato che gli effetti negativi a livello psicologico si possono mantenere anche nel lungo termine dall’insorgenza della pandemia.
4 October 2023 in Research Square
Background/aims In order to make the centers more attractive to trial sponsors, in recent years some research institutions around the world have pursued projects to reorganize the pathway of trial activation, developing new organizational models to improve the activation process and reduce its times. This study aims at analyzing and reorganizing the start-up phase of trials conducted at the Research and Innovation Department (DAIRI) of the Public Hospital of Alessandria (Italy). Methods A project was carried out to reorganize the trial authorization process at DAIRI by involving the three facilities responsible for this pathway: Clinical Trial Center (CTC), Ethics Committee Secretariat (ESC) and Administrative Coordination (AC). Lean Thinking methodology was used with the A3 report tool and the analysis was carried out by monitoring specific key performance indicators, derived from variables representing highlights of the trials' activation pathway. The project involved phases of analysis, implementation of identified countermeasures and monitoring of timelines in 8 four-month periods. The overall mean and median values of studies activation times were calculated, as well as the average times for each facility involved in the process. Results In this study, 298 studies both sponsored by research associations and industry with both observational and interventional study design were monitored. The mean trial activation time was reduced from 218 days before the project to 56 days in the last period monitored. From the first to the last monitoring period, each facility involved achieved at least a halving of the average time required to carry out its activities in the clinical trials activation pathway (CTC: 55 days vs 23, ECS: 25 days vs 8, AC 29 days vs 10). Average activation time for studies with agreement remains longer than those without agreement (100 days vs. 46). Conclusions The reorganization project emphasized the importance of having clinical and administrative staff specifically trained on the trial activation process. This reorganization led to the development of a standard operating procedure and a tool to monitor the time (KPIs of the process) that can also be implemented in other clinical centers.
26 March 2024 in Working Paper of Public Health
Aims: prognostic impact of mutations in BRAF and KRAS genes in patients with colorectal cancer was evaluated to detect variations in survival among patients with these mutations, in relation to different morphologic features identified at diagnosis and the expression of mismatch repair proteins. The final purpose of the project will be to establish models to predict variations in survival in different subsets of patients with colorectal cancer. Materials and Methods: partial survival analyses were conducted on 32 subjects in relation to three different variables: mutation in BRAF or KRAS genes, expression of mismatch repair system and morphological features of the tumor. Results: preliminary results of this study provide evidence that survival in different subsets of patients with colorectal cancer can be influenced by several factors, which include, in addition to immunohistochemical and molecular investigations, the assessment of different morphological features. Conclusions: Integrating different characteristics may reveal which factors have a more significant impact on survival in these subgroups. More patients will be needed to design different survival models and to check these preliminary results more effectively. Obiettivi: l’impatto prognostico delle mutazioni nei geni BRAF e KRAS nei pazienti con tumore del colon-retto è stato valutato per individuare le variazioni di sopravvivenza tra i pazienti con queste mutazioni, in relazione alle diverse caratteristiche morfologiche identificate alla diagnosi ed all’espressione delle proteine di Mismatch Repair. Lo scopo finale del progetto sarà quello di stabilire modelli per prevedere le variazioni di sopravvivenza in diversi sottoinsiemi di pazienti con tumore del colon-retto. Materiali e Metodi: sono state condotte analisi di sopravvivenza parziale su 32 soggetti in relazione a tre diverse variabili: mutazione nei geni BRAF o KRAS, espressione delle proteine dei Mismatch Repair e caratteristiche morfologiche del tumore. Risultati: i risultati preliminari di questo studio dimostrano che la sopravvivenza in diverse sottopopolazioni di pazienti con tumore del colon-retto può essere influenzata da diversi fattori, che includono, oltre alle indagini immunoistochimiche e molecolari, la valutazione di diverse caratteristiche morfologiche. Conclusioni: l’integrazione di diverse caratteristiche può rivelare quali fattori abbiano un impatto più significativo sulla sopravvivenza in questi sottogruppi. Sarà necessario un numero maggiore di pazienti per progettare diversi modelli di sopravvivenza e verificare in maniera più efficace questi risultati preliminari.
14 October 2024 in Working Paper of Public Health
Background: one under-researched line of investigation is gliomas, which are a group of malignant brain tumours with highly poor prognoses. Despite efforts to identify environmental risk factors for gliomas, their etiology still remains unclear. It turns out that several future developments are needed in order to understand other potential risk factors. To this end, the primary objective of the present pilot study is to conduct an assessment of the spatial distribution of high-grade brain tumor cases in the province of Alessandria, where possible risk factors such as the presence of chemical industries and asbestiform fibers are found. Materials and Methods: the study sample consisted of all patients diagnosed with high-grade glioma between January 2018 and April 2023, residents in the province of Alessandria at the time of diagnosis and referred to the health facilities of the "Azienda Sanitaria Locale di Alessandria" and the "Azienda Universitario-Ospedaliera di Alessandria". Biographical and pathological history variables were collected, and finally, data were processed in aggregate and anonymized form. A total of 103 deceased patients were enrolled, stratified by age and type of diagnosis. Results: it was seen that the city with the most cases was Alessandria, with 27 diagnoses found during the period under review (26.2%), followed by cities of Acqui Terme, Casale Monferrato, and Novi Ligure with seven diagnoses (6.8%). Preliminary results presented in this paper were compared with data already published. Conclusions: analyses performed to arrive at an initial geographical distribution of high-grade glioma diagnoses are consistent relative to the population density of each municipality considered.